Clinical Trial Update: Vascular Augmentation of Late-life Unremitted Depression (VALUeD) [Phase 3]

View source ↗

Summary

An update on the Phase 3 trial evaluating vascular augmentation for late-life unremitted depression (VALUeD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Gateshead Health NHS Foundation Trust | Conditions: Depression | Phase 3 | Status: UNKNOWN